Rare diseases
Investigational molecules
Locations
Back to Greece1 008 clinical trials in Chaidari, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study on Emapalumab for Patients with Sepsis Linked to Interferon-Gamma
GreeceStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis
GreeceStudy on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
GreeceStudy of Retifanlimab, INCAGN02385, and INCAGN02390 for First-Line Treatment in Patients with PD-L1 Positive Recurrent/Metastatic Head and Neck Cancer
GreeceStudy on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid
GreeceStudy on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors
GreeceStudy on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack
GreeceStudy Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer
GreeceStudy on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib
GreeceStudy on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment
GreeceStudy on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis
GreeceStudy of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on squamous cell carcinoma of the head and neck, exploring combination therapy approaches that integrate immunotherapy with traditional treatments.
The study evaluates the effectiveness of combining nivolumab with standard cisplatin-radiotherapy, aiming to improve disease-free survival rates in patients with resected head and neck cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
